APO Research

APO RESEARCH · REPORT

Legal Surrogacy

Selected research

Market Outlook & Growth Opportunities

Global Legal Surrogacy Market Outlook and Growth Opportunities 2026

Market perspective

The global Legal Surrogacy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Legal Surrogacy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Legal Surrogacy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Legal Surrogacy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Legal Surrogacy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Legal Surrogacy market include New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions and Cardone & Associates Reproductive Medicine & Infertility, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Legal Surrogacy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Legal Surrogacy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Legal Surrogacy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Legal Surrogacy market.

Legal Surrogacy Segment by Company

New Hope Fertility Center

IVI-RMA Global

Scanfert AVA Clinic

Bourn Hall Fertility Clinic

Nova IVI Fertility

Ovation Fertility

Bangkok IVF Center

Extraordinary Conceptions

Cardone & Associates Reproductive Medicine & Infertility

Max Healthcare

Growing Generations

Circle Surrogacy

Morpheus Life Sciences

Legal Surrogacy Segment by Type

Intrauterine Insemination (IUI)

In-vitro Fertilization (IVF)

Others

Legal Surrogacy Segment by Application

Below 35 Years

35-45 Years

Over 45 Years

Legal Surrogacy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Legal Surrogacy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Legal Surrogacy key companies, revenue, market share, and recent developments.

3. To split the Legal Surrogacy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Legal Surrogacy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Legal Surrogacy significant trends, drivers, influence factors in global and regions.

6. To analyze Legal Surrogacy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Legal Surrogacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Legal Surrogacy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Legal Surrogacy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Legal Surrogacy industry.

Chapter 3: Detailed analysis of Legal Surrogacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Legal Surrogacy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Legal Surrogacy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Legal Surrogacy Industry Trends Table 2. Legal Surrogacy Industry Drivers Table 3. Legal Surrogacy Industry Opportunities and Challenges Table 4. Legal Surrogacy Industry Restraints Table 5. Global Legal Surrogacy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Legal Surrogacy Revenue Share by Company (2021-2026) Table 7. Global Legal Surrogacy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Legal Surrogacy Key Company Manufacturing Base & Headquarters Table 9. Global Legal Surrogacy Company, Product Type & Application Table 10. Global Legal Surrogacy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Legal Surrogacy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Intrauterine Insemination (IUI) Table 15. Significant Companies of In-vitro Fertilization (IVF) Table 16. Significant Companies of Others Table 17. Global Legal Surrogacy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Legal Surrogacy Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Legal Surrogacy Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Legal Surrogacy Sales Value Share by Type (2021-2026) Table 21. Global Legal Surrogacy Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Below 35 Years Table 23. Significant Companies of 35-45 Years Table 24. Significant Companies of Over 45 Years Table 25. Global Legal Surrogacy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Legal Surrogacy Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Legal Surrogacy Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Legal Surrogacy Sales Value Share by Application (2021-2026) Table 29. Global Legal Surrogacy Sales Value Share by Application (2027-2032) Table 30. Global Legal Surrogacy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Legal Surrogacy Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Legal Surrogacy Sales Value Share by Region (2021-2026) Table 33. Global Legal Surrogacy Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Legal Surrogacy Sales Value Share by Region (2027-2032) Table 35. Global Legal Surrogacy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Legal Surrogacy Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Legal Surrogacy Sales Value Market Share by Country (2021-2026) Table 38. Global Legal Surrogacy Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Legal Surrogacy Sales Value Market Share by Country (2027-2032) Table 40. New Hope Fertility Center Company Information Table 41. New Hope Fertility Center Business Overview Table 42. New Hope Fertility Center Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. New Hope Fertility Center Legal Surrogacy Product Portfolio Table 44. New Hope Fertility Center Recent Development Table 45. IVI-RMA Global Company Information Table 46. IVI-RMA Global Business Overview Table 47. IVI-RMA Global Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. IVI-RMA Global Legal Surrogacy Product Portfolio Table 49. IVI-RMA Global Recent Development Table 50. Scanfert AVA Clinic Company Information Table 51. Scanfert AVA Clinic Business Overview Table 52. Scanfert AVA Clinic Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Scanfert AVA Clinic Legal Surrogacy Product Portfolio Table 54. Scanfert AVA Clinic Recent Development Table 55. Bourn Hall Fertility Clinic Company Information Table 56. Bourn Hall Fertility Clinic Business Overview Table 57. Bourn Hall Fertility Clinic Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bourn Hall Fertility Clinic Legal Surrogacy Product Portfolio Table 59. Bourn Hall Fertility Clinic Recent Development Table 60. Nova IVI Fertility Company Information Table 61. Nova IVI Fertility Business Overview Table 62. Nova IVI Fertility Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Nova IVI Fertility Legal Surrogacy Product Portfolio Table 64. Nova IVI Fertility Recent Development Table 65. Ovation Fertility Company Information Table 66. Ovation Fertility Business Overview Table 67. Ovation Fertility Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Ovation Fertility Legal Surrogacy Product Portfolio Table 69. Ovation Fertility Recent Development Table 70. Bangkok IVF Center Company Information Table 71. Bangkok IVF Center Business Overview Table 72. Bangkok IVF Center Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bangkok IVF Center Legal Surrogacy Product Portfolio Table 74. Bangkok IVF Center Recent Development Table 75. Extraordinary Conceptions Company Information Table 76. Extraordinary Conceptions Business Overview Table 77. Extraordinary Conceptions Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Extraordinary Conceptions Legal Surrogacy Product Portfolio Table 79. Extraordinary Conceptions Recent Development Table 80. Cardone & Associates Reproductive Medicine & Infertility Company Information Table 81. Cardone & Associates Reproductive Medicine & Infertility Business Overview Table 82. Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Product Portfolio Table 84. Cardone & Associates Reproductive Medicine & Infertility Recent Development Table 85. Max Healthcare Company Information Table 86. Max Healthcare Business Overview Table 87. Max Healthcare Legal Surrogacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Max Healthcare Legal Surrogacy Product Portfolio Table 89. Max Healthcare Recent Development Table 90. Growing Generations Company Information Table 91. Growing Generations Business Overview Table 92. Growing Generations Legal Surrogacy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Growing Generations Legal Surrogacy Product Portfolio Table 94. Growing Generations Recent Development Table 95. Circle Surrogacy Company Information Table 96. Circle Surrogacy Business Overview Table 97. Circle Surrogacy Legal Surrogacy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Circle Surrogacy Legal Surrogacy Product Portfolio Table 99. Circle Surrogacy Recent Development Table 100. Morpheus Life Sciences Company Information Table 101. Morpheus Life Sciences Business Overview Table 102. Morpheus Life Sciences Legal Surrogacy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Morpheus Life Sciences Legal Surrogacy Product Portfolio Table 104. Morpheus Life Sciences Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Legal Surrogacy Product Image Figure 2. Global Legal Surrogacy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Legal Surrogacy Market Size (2021-2032) & (US$ Million) Figure 4. Global Legal Surrogacy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Intrauterine Insemination (IUI) Image Figure 8. In-vitro Fertilization (IVF) Image Figure 9. Others Image Figure 10. Global Legal Surrogacy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Legal Surrogacy Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Legal Surrogacy Sales Value Share by Type (2021-2032) Figure 13. Below 35 Years Image Figure 14. 35-45 Years Image Figure 15. Over 45 Years Image Figure 16. Global Legal Surrogacy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Legal Surrogacy Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Legal Surrogacy Sales Value Share by Application (2021-2032) Figure 19. Global Legal Surrogacy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Legal Surrogacy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Legal Surrogacy Sales Value (2021-2032) & (US$ Million) Figure 22. North America Legal Surrogacy Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Legal Surrogacy Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Legal Surrogacy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Legal Surrogacy Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Legal Surrogacy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Legal Surrogacy Sales Value (2021-2032) & (US$ Million) Figure 28. South America Legal Surrogacy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Legal Surrogacy Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Legal Surrogacy Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Legal Surrogacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Legal Surrogacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Legal Surrogacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Intrauterine Insemination (IUI)
  • In-vitro Fertilization (IVF)
  • Others
Applications
  • Below 35 Years
  • 35-45 Years
  • Over 45 Years
Companies covered
  • New Hope Fertility Center
  • IVI-RMA Global
  • Scanfert AVA Clinic
  • Bourn Hall Fertility Clinic
  • Nova IVI Fertility
  • Ovation Fertility
  • Bangkok IVF Center
  • Extraordinary Conceptions
  • Cardone & Associates Reproductive Medicine & Infertility
  • Max Healthcare
  • Growing Generations
  • Circle Surrogacy
  • Morpheus Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Legal Surrogacy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Legal Surrogacy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Legal Surrogacy Market Dynamics
  1. 2.1 Legal Surrogacy Industry Trends
  2. 2.2 Legal Surrogacy Industry Drivers
  3. 2.3 Legal Surrogacy Industry Opportunities and Challenges
  4. 2.4 Legal Surrogacy Industry Restraints
3 Legal Surrogacy Market by Company
  1. 3.1 Global Legal Surrogacy Company Revenue Ranking in 2025
  2. 3.2 Global Legal Surrogacy Revenue by Company (2021-2026)
  3. 3.3 Global Legal Surrogacy Company Ranking (2024-2026)
  4. 3.4 Global Legal Surrogacy Company Manufacturing Base and Headquarters
  5. 3.5 Global Legal Surrogacy Company Product Type and Application
  6. 3.6 Global Legal Surrogacy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Legal Surrogacy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Legal Surrogacy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Legal Surrogacy Market by Type
  1. 4.1 Legal Surrogacy Type Introduction
  2. 4.1.1 Intrauterine Insemination (IUI)
  3. 4.1.2 In-vitro Fertilization (IVF)
  4. 4.1.3 Others
  5. 4.2 Global Legal Surrogacy Sales Value by Type
  6. 4.2.1 Global Legal Surrogacy Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Legal Surrogacy Sales Value by Type (2021-2032)
  8. 4.2.3 Global Legal Surrogacy Sales Value Share by Type (2021-2032)
5 Legal Surrogacy Market by Application
  1. 5.1 Legal Surrogacy Application Introduction
  2. 5.1.1 Below 35 Years
  3. 5.1.2 35-45 Years
  4. 5.1.3 Over 45 Years
  5. 5.2 Global Legal Surrogacy Sales Value by Application
  6. 5.2.1 Global Legal Surrogacy Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Legal Surrogacy Sales Value by Application (2021-2032)
  8. 5.2.3 Global Legal Surrogacy Sales Value Share by Application (2021-2032)
6 Legal Surrogacy Regional Value Analysis
  1. 6.1 Global Legal Surrogacy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Legal Surrogacy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Legal Surrogacy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Legal Surrogacy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Legal Surrogacy Sales Value (2021-2032)
  7. 6.3.2 North America Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Legal Surrogacy Sales Value (2021-2032)
  10. 6.4.2 Europe Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Legal Surrogacy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Legal Surrogacy Sales Value (2021-2032)
  16. 6.6.2 South America Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Legal Surrogacy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
7 Legal Surrogacy Country-level Value Analysis
  1. 7.1 Global Legal Surrogacy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Legal Surrogacy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Legal Surrogacy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Legal Surrogacy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Legal Surrogacy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Legal Surrogacy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Legal Surrogacy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Legal Surrogacy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Legal Surrogacy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Legal Surrogacy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Legal Surrogacy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Legal Surrogacy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Legal Surrogacy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Legal Surrogacy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Legal Surrogacy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Legal Surrogacy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Legal Surrogacy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Legal Surrogacy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Legal Surrogacy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Legal Surrogacy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Legal Surrogacy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Legal Surrogacy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Legal Surrogacy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Legal Surrogacy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Legal Surrogacy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Legal Surrogacy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Legal Surrogacy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Legal Surrogacy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Legal Surrogacy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Legal Surrogacy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Legal Surrogacy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Legal Surrogacy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 New Hope Fertility Center
  2. 8.1.1 New Hope Fertility Center Company Information
  3. 8.1.2 New Hope Fertility Center Business Overview
  4. 8.1.3 New Hope Fertility Center Legal Surrogacy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 New Hope Fertility Center Legal Surrogacy Product Portfolio
  6. 8.1.5 New Hope Fertility Center Recent Developments
  7. 8.2 IVI-RMA Global
  8. 8.2.1 IVI-RMA Global Company Information
  9. 8.2.2 IVI-RMA Global Business Overview
  10. 8.2.3 IVI-RMA Global Legal Surrogacy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IVI-RMA Global Legal Surrogacy Product Portfolio
  12. 8.2.5 IVI-RMA Global Recent Developments
  13. 8.3 Scanfert AVA Clinic
  14. 8.3.1 Scanfert AVA Clinic Company Information
  15. 8.3.2 Scanfert AVA Clinic Business Overview
  16. 8.3.3 Scanfert AVA Clinic Legal Surrogacy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Scanfert AVA Clinic Legal Surrogacy Product Portfolio
  18. 8.3.5 Scanfert AVA Clinic Recent Developments
  19. 8.4 Bourn Hall Fertility Clinic
  20. 8.4.1 Bourn Hall Fertility Clinic Company Information
  21. 8.4.2 Bourn Hall Fertility Clinic Business Overview
  22. 8.4.3 Bourn Hall Fertility Clinic Legal Surrogacy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bourn Hall Fertility Clinic Legal Surrogacy Product Portfolio
  24. 8.4.5 Bourn Hall Fertility Clinic Recent Developments
  25. 8.5 Nova IVI Fertility
  26. 8.5.1 Nova IVI Fertility Company Information
  27. 8.5.2 Nova IVI Fertility Business Overview
  28. 8.5.3 Nova IVI Fertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nova IVI Fertility Legal Surrogacy Product Portfolio
  30. 8.5.5 Nova IVI Fertility Recent Developments
  31. 8.6 Ovation Fertility
  32. 8.6.1 Ovation Fertility Company Information
  33. 8.6.2 Ovation Fertility Business Overview
  34. 8.6.3 Ovation Fertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ovation Fertility Legal Surrogacy Product Portfolio
  36. 8.6.5 Ovation Fertility Recent Developments
  37. 8.7 Bangkok IVF Center
  38. 8.7.1 Bangkok IVF Center Company Information
  39. 8.7.2 Bangkok IVF Center Business Overview
  40. 8.7.3 Bangkok IVF Center Legal Surrogacy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bangkok IVF Center Legal Surrogacy Product Portfolio
  42. 8.7.5 Bangkok IVF Center Recent Developments
  43. 8.8 Extraordinary Conceptions
  44. 8.8.1 Extraordinary Conceptions Company Information
  45. 8.8.2 Extraordinary Conceptions Business Overview
  46. 8.8.3 Extraordinary Conceptions Legal Surrogacy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Extraordinary Conceptions Legal Surrogacy Product Portfolio
  48. 8.8.5 Extraordinary Conceptions Recent Developments
  49. 8.9 Cardone & Associates Reproductive Medicine & Infertility
  50. 8.9.1 Cardone & Associates Reproductive Medicine & Infertility Company Information
  51. 8.9.2 Cardone & Associates Reproductive Medicine & Infertility Business Overview
  52. 8.9.3 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Product Portfolio
  54. 8.9.5 Cardone & Associates Reproductive Medicine & Infertility Recent Developments
  55. 8.10 Max Healthcare
  56. 8.10.1 Max Healthcare Company Information
  57. 8.10.2 Max Healthcare Business Overview
  58. 8.10.3 Max Healthcare Legal Surrogacy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Max Healthcare Legal Surrogacy Product Portfolio
  60. 8.10.5 Max Healthcare Recent Developments
  61. 8.11 Growing Generations
  62. 8.11.1 Growing Generations Company Information
  63. 8.11.2 Growing Generations Business Overview
  64. 8.11.3 Growing Generations Legal Surrogacy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Growing Generations Legal Surrogacy Product Portfolio
  66. 8.11.5 Growing Generations Recent Developments
  67. 8.12 Circle Surrogacy
  68. 8.12.1 Circle Surrogacy Company Information
  69. 8.12.2 Circle Surrogacy Business Overview
  70. 8.12.3 Circle Surrogacy Legal Surrogacy Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Circle Surrogacy Legal Surrogacy Product Portfolio
  72. 8.12.5 Circle Surrogacy Recent Developments
  73. 8.13 Morpheus Life Sciences
  74. 8.13.1 Morpheus Life Sciences Company Information
  75. 8.13.2 Morpheus Life Sciences Business Overview
  76. 8.13.3 Morpheus Life Sciences Legal Surrogacy Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Morpheus Life Sciences Legal Surrogacy Product Portfolio
  78. 8.13.5 Morpheus Life Sciences Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research